Showing results (2301-2310 of 2,927) with videos related to

Sort By:
Pageof 293
Clinical Pharmacology and Therapeutics|May 21, 2019
Clopidogrel Drug Interactions and Serious Bleeding: Generating Real-World Evidence via Automated High-Throughput Pharmacoepidemiologic ScreeningCharles E Leonard, Meijia Zhou, Colleen M Brensinger, et al.
Annals of Surgery|February 1, 1985
The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapyJ R Harris, J L Connolly, S J Schnitt, et al.
British Journal of Cancer|May 13, 2004
A prognostic index for operable, node-negative breast cancerM McCallum, C Baker, K Gillespie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2008
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignanciesM von Mehren, R J Schilder, J D Cheng, et al.
The Prostate|January 22, 2013
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pinJason Gee, Howard Bailey, Kyungmann Kim, et al.
Cancer|July 1, 1977
The effect of thymosin on patients with disseminated malignancies. A phase I studyJ J Costanzi, R G Gagliano, F Delaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000
Enhancement of platelet recovery after myelosuppressive chemotherapy by recombinant human megakaryocyte growth and development factor in patients with advanced cancerR L Basser, C Underhill, I Davis, et al.
British Journal of Cancer|September 16, 1999
A polymorphism in the CYP17 gene is associated with male breast cancerI E Young, K M Kurian, C Annink, et al.
Anti-Cancer Drugs|May 29, 2015
Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignanciesOlivier Rixe, Igor Puzanov, Patricia M LoRusso, et al.
The Journal of Rheumatology|June 2, 2004
The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritisKaren E Hansen, Julie P Hildebrand, Mark C Genovese, et al.
Pageof 293